NASDAQ · Financial Statements
Bambusa Therapeutics Inc. (BBTX) Revenue, Earnings & Financial Statements
$16.13
NASDAQ: BBTX
Market Cap $802.42M
Data as of Nov 16, 2026 (intraday, delayed) · Source: Financial Modeling Prep (methodology)
Full income statement, balance sheet, and cash flow statement for Bambusa Therapeutics Inc. (BBTX), plus valuation and return ratios.
Annual financials are not yet available for this stock.
Revenue and earnings of other Biotechnology stocks
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.